APOE and metabolic dysfunction-associated steatohepatitis: The pharmacological inhibition of NE by treatment with sivelestat reduced the serum transaminase activity, expression of inflammatory mediators, and NASH score in Apoe-deficient mice fed with an HFHCD that showed NASH phenotypes (142).